search
Possibility
Back
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set actionable strategy
Build products, services, and experiences
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Safer societies
Regenerative futures
Impact
Culture
About
Careers
Contact
Skip to content
search
Possibility
Possibility
Explore our work: what we do, how we do it, and the value we create for our clients.
Industries
Consumer and manufacturing
Defence and security
Energy and utilities
Financial services
Government and public sector
Health
Life sciences
Transport
Services
Set actionable strategy
Build products, services, and experiences
Reimagine AI, digital, and data
Improve organisational performance
Deliver complex programmes
Empower your people
Global Shifts
Empowered consumers
Healthier humans
Future organisations
Safer societies
Regenerative futures
Impact
Culture
About
Careers
Contact
Pharma and biotech
(optional)
All article types
Client story
In the media
Press release
Report
Insight
Apply
Reset
Showing 1-10 of 89 results
Sort by:
Relevance
Date
Spotlight
Redefine possible
How pharma leaders can break from the expected to deliver faster, better patient outcomes.
In the media
How to rebuild the pharma operating model for an AI era
Why operating model change, not technology, determines AI success in pharma.
PharmExec
20 August 2026
In the media
Pharma R&D pipeline productivity: Three ways to enhance bandwidth and efficiency
Boost pharma R&D productivity through smarter resourcing, technology innovation, and disciplined execution across clinical pipelines.
Clinical Leader
22 July 2026
Spotlight
Regulatory and quality compliance
Transform regulatory and quality operations to accelerate timelines, strengthen compliance, and deliver better patient outcomes.
In the media
Beyond GLP-1s: Competing in the era of consumerized therapeutics
GLP‑1s are reshaping pharma as patient-consumers take control of treatment access and decisions.
Life Science Leader
15 May 2026
In the media
Cell and gene therapies: The emerging reality for scalable market readiness
Why CGT commercialization is failing and what must change next.
Cell and Gene
08 May 2026
In the media
AI won’t fix clinical development until pharma changes how they use it
Why AI pilots fail in pharma and what actually improves clinical development performance.
Clinical Leader
28 April 2026
In the media
Smarter safety stocks for a volatile world: Harnessing artificial intelligence and real-time data for resilient pharmaceutical supply chains
How AI and quality data reshape inventory, lead times and resilience in pharma.
Chemistry Today
17 April 2026
In the media
Building confidence in clinical trial data and technology processes
Early, end‑to‑end data validation that prevents study delays and improves clinical trial quality.
Applied Clinical Trials
20 March 2026
In the media
Breakthroughs in the lab – Blind spots in reality
GLP-1-driven obesity care needs personalized, real-world systems to sustain long‑term outcomes.
Life Science Daily News
11 March 2026
Next
Current page:
1
2
3
4
5
6
7
8
9
of 9
Current page: 1 of 9